Bausch Health Cos SG&A Expenses 2010-2024 | BHC
Bausch Health Cos sg&a expenses from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
Bausch Health Cos Annual SG&A Expenses
(Millions of US $) |
| 2023 |
$2,917 |
| 2022 |
$2,625 |
| 2021 |
$2,624 |
| 2020 |
$2,367 |
| 2019 |
$2,554 |
| 2018 |
$2,473 |
| 2017 |
$2,582 |
| 2016 |
$2,810 |
| 2015 |
$2,700 |
| 2014 |
$2,026 |
| 2013 |
$1,305 |
| 2012 |
$756 |
| 2011 |
$572 |
| 2010 |
$277 |
| 2009 |
$168 |
Bausch Health Cos Quarterly SG&A Expenses
(Millions of US $) |
| 2024-09-30 |
$850 |
| 2024-06-30 |
$832 |
| 2024-03-31 |
$794 |
| 2023-12-31 |
$766 |
| 2023-09-30 |
$715 |
| 2023-06-30 |
$711 |
| 2023-03-31 |
$725 |
| 2022-12-31 |
$666 |
| 2022-09-30 |
$661 |
| 2022-06-30 |
$676 |
| 2022-03-31 |
$622 |
| 2021-12-31 |
$680 |
| 2021-09-30 |
$653 |
| 2021-06-30 |
$685 |
| 2021-03-31 |
$606 |
| 2020-12-31 |
$636 |
| 2020-09-30 |
$572 |
| 2020-06-30 |
$526 |
| 2020-03-31 |
$633 |
| 2019-12-31 |
$668 |
| 2019-09-30 |
$648 |
| 2019-06-30 |
$651 |
| 2019-03-31 |
$587 |
| 2018-12-31 |
$626 |
| 2018-09-30 |
$614 |
| 2018-06-30 |
$642 |
| 2018-03-31 |
$591 |
| 2017-12-31 |
$639 |
| 2017-09-30 |
$623 |
| 2017-06-30 |
$659 |
| 2017-03-31 |
$661 |
| 2016-12-31 |
$665 |
| 2016-09-30 |
$661 |
| 2016-06-30 |
$671 |
| 2016-03-31 |
$813 |
| 2015-12-31 |
$743 |
| 2015-09-30 |
$698 |
| 2015-06-30 |
$686 |
| 2015-03-31 |
$574 |
| 2014-12-31 |
$524 |
| 2014-09-30 |
$504 |
| 2014-06-30 |
$516 |
| 2014-03-31 |
$482 |
| 2013-12-31 |
$450 |
| 2013-09-30 |
$356 |
| 2013-06-30 |
$257 |
| 2013-03-31 |
$242 |
| 2012-12-31 |
$205 |
| 2012-09-30 |
$189 |
| 2012-06-30 |
$185 |
| 2012-03-31 |
$177 |
| 2011-12-31 |
$149 |
| 2011-09-30 |
$135 |
| 2011-06-30 |
$150 |
| 2011-03-31 |
$140 |
| 2010-12-31 |
$128 |
| 2010-09-30 |
$60 |
| 2010-06-30 |
$45 |
| 2010-03-31 |
$44 |
| 2009-12-31 |
$30 |
| 2009-09-30 |
$45 |
| 2009-06-30 |
$49 |
| 2009-03-31 |
$43 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$2.931B |
$8.757B |
|
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|
